[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100509886":3},{"organization":4,"armGroups":7,"interventions":77,"overallOfficials":111,"centralContacts":115,"locations":121,"responsibleParty":567,"collaborators":83,"id":569,"slug":570,"hasResults":571,"nctId":572,"briefTitle":573,"officialTitle":574,"acronym":83,"eligibilityCriteria":575,"healthyVolunteers":571,"sex":576,"minAge":577,"maxAge":83,"enrollmentInfo":578,"targetDuration":83,"studyType":581,"phases":582,"briefSummary":585,"conditions":586,"keywords":602,"overallStatus":124,"whyStopped":83,"lastUpdateSubmitDate":611,"lastUpdatePostDateStruct":612,"startDateStruct":615,"completionDateStruct":617,"leadSponsor":619,"locationsCount":620},{"fullName":5,"class":6},"Parabilis Medicines, Inc.","INDUSTRY",[8,14,18,22,26,29,34,39,43,47,50,54,58,61,64,68,71,74],{"label":9,"type":10,"description":11,"interventionNames":12},"Part 1a","EXPERIMENTAL","Solid Tumors with any WNT-Pathway Activating Mutation (WPAM) or Microsatellite Stable (MSS) Colorectal Cancer (CRC), irrespective of WPAM status",[13],"Drug: FOG-001",{"label":15,"type":10,"description":16,"interventionNames":17},"Part 1b","MSS CRC (known WPAM negative participants are not eligible)",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Part 1c","Hepatocellular Carcinoma (documented WPAM in APC or CTNNB1 required)",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Part 1d-1","Desmoid Tumors",[13],{"label":27,"type":10,"description":24,"interventionNames":28},"Part 1d-2",[13],{"label":30,"type":10,"description":16,"interventionNames":31},"Part 1f-1",[13,32,33],"Drug: mFOLFOX-6","Drug: Bevacizumab",{"label":35,"type":10,"description":36,"interventionNames":37},"Part 1f-2","Solid Tumors with documented WPAM or MSS CRC (known WPAM negative participants are not eligible)",[13,38],"Drug: Nivolumab",{"label":40,"type":10,"description":16,"interventionNames":41},"Part 1f-3",[13,42,33],"Drug: Trifluridine\u002Ftipiracil",{"label":44,"type":10,"description":45,"interventionNames":46},"Part 1g","Solid Tumors with documented WPAM (known WPAM negative participants are not eligible)",[13],{"label":48,"type":10,"description":24,"interventionNames":49},"Part 1h",[13],{"label":51,"type":10,"description":52,"interventionNames":53},"Part 2a","MSS CRC, irrespective of WPAM status",[13],{"label":55,"type":10,"description":56,"interventionNames":57},"Part 2b","Solid Tumors with documented WPAM",[13],{"label":59,"type":10,"description":20,"interventionNames":60},"Part 2c",[13],{"label":62,"type":10,"description":24,"interventionNames":63},"Part 2d",[13],{"label":65,"type":10,"description":66,"interventionNames":67},"Part 2e","Metastatic Castration-Resistant Prostate Cancer (documented WPAM in APC or CTNNB1 required)",[13],{"label":69,"type":10,"description":16,"interventionNames":70},"Part 2f-1",[13,32,33],{"label":72,"type":10,"description":36,"interventionNames":73},"Part 2f-2",[13,38],{"label":75,"type":10,"description":16,"interventionNames":76},"Part 2f-3",[13,42,33],[78,84,90,96,102,108],{"type":79,"name":80,"description":81,"armGroupLabels":82,"otherNames":83},"DRUG","FOG-001","FOG-001 will be administered IV at assigned doses in continuous cycles of 28 days",[9,15,19,23,27,30,35,40,51,55,59,62,65,69,72,75],null,{"type":79,"name":85,"description":86,"armGroupLabels":87,"otherNames":88},"mFOLFOX-6","mFOLFOX-6 will be administered per the prescribing information in combination with FOG-001",[30,69],[89],"Leucovorin, 5-fluorouracil, Oxaliplatin",{"type":79,"name":91,"description":92,"armGroupLabels":93,"otherNames":94},"Nivolumab","Nivolumab will be administered per the prescribing information in combination with FOG-001",[35,72],[95],"Opdivo",{"type":79,"name":97,"description":98,"armGroupLabels":99,"otherNames":100},"Trifluridine\u002Ftipiracil","Trifluridine\u002Ftipiracil will be administered per the prescribing information in combination with FOG-001",[40,75],[101],"Lonsurf",{"type":79,"name":103,"description":104,"armGroupLabels":105,"otherNames":106},"Bevacizumab","Bevacizumab will be administered per the prescribing information in combination with FOG-001",[30,40,69,75],[107],"Avastin",{"type":79,"name":80,"description":109,"armGroupLabels":110,"otherNames":83},"FOG-001 will be administered subcutaneous at assigned doses in continuous cycles of 28 days",[44,48],[112],{"name":113,"affiliation":5,"role":114},"Jorge Ramos, DO","STUDY_CHAIR",[116],{"name":117,"role":118,"phone":119,"phoneExt":83,"email":120},"Clinical Trial Inquiries","CONTACT","(857) 259-6305","clinicaltrials@parabilismed.com",[122,140,153,166,180,193,206,219,233,247,261,274,284,299,313,323,337,349,363,376,390,404,417,431,445,458,472,482,496,509,523,537,553],{"facility":123,"status":124,"city":125,"state":126,"zip":127,"country":128,"countryCode":129,"cosmosGeoPoint":130,"geoPoint":135,"contacts":136},"Mayo Clinic","RECRUITING","Phoenix","Arizona","85054","United States","US",{"type":131,"coordinates":132},"Point",[133,134],-112.07404,33.44838,{"lat":134,"lon":133},[137],{"name":138,"role":118,"phone":139,"phoneExt":83,"email":83},"Mahesh Seetharam, MD","480-301-8000",{"facility":141,"status":124,"city":142,"state":126,"zip":143,"country":128,"countryCode":129,"cosmosGeoPoint":144,"geoPoint":148,"contacts":149},"Honor Health","Scottsdale","85258",{"type":131,"coordinates":145},[146,147],-111.89903,33.50921,{"lat":147,"lon":146},[150],{"name":151,"role":118,"phone":152,"phoneExt":83,"email":83},"Sunil Sharma, MD","480-323-1350",{"facility":154,"status":124,"city":155,"state":126,"zip":156,"country":128,"countryCode":129,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Arizona Cancer Center at University of Arizona","Tucson","85719",{"type":131,"coordinates":158},[159,160],-110.92648,32.22174,{"lat":160,"lon":159},[163],{"name":164,"role":118,"phone":165,"phoneExt":83,"email":83},"Aaron Scott, MD","520-694-2873",{"facility":167,"status":124,"city":168,"state":169,"zip":170,"country":128,"countryCode":129,"cosmosGeoPoint":171,"geoPoint":175,"contacts":176},"University of California, Los Angeles (UCLA)","Los Angeles","California","90095",{"type":131,"coordinates":172},[173,174],-118.24368,34.05223,{"lat":174,"lon":173},[177],{"name":178,"role":118,"phone":179,"phoneExt":83,"email":83},"Randy Hecht, MD","310-829-5471",{"facility":181,"status":124,"city":182,"state":169,"zip":183,"country":128,"countryCode":129,"cosmosGeoPoint":184,"geoPoint":188,"contacts":189},"Stanford Cancer Institute, Stanford University","Palo Alto","94304",{"type":131,"coordinates":185},[186,187],-122.14302,37.44188,{"lat":187,"lon":186},[190],{"name":191,"role":118,"phone":192,"phoneExt":83,"email":83},"Nam Bui","650-498-6000",{"facility":194,"status":124,"city":195,"state":169,"zip":196,"country":128,"countryCode":129,"cosmosGeoPoint":197,"geoPoint":201,"contacts":202},"University of California San Francisco, Helen Diller Family Comprehensive Cancer Center","San Francisco","94158",{"type":131,"coordinates":198},[199,200],-122.41942,37.77493,{"lat":200,"lon":199},[203],{"name":204,"role":118,"phone":205,"phoneExt":83,"email":83},"Varun Monga, MD","888-689-8273",{"facility":207,"status":124,"city":208,"state":169,"zip":209,"country":128,"countryCode":129,"cosmosGeoPoint":210,"geoPoint":214,"contacts":215},"Sarcoma Oncology Center","Santa Monica","90403",{"type":131,"coordinates":211},[212,213],-118.49138,34.01949,{"lat":213,"lon":212},[216],{"name":217,"role":118,"phone":218,"phoneExt":83,"email":83},"Sant Chawla, MD","301-552-9999",{"facility":220,"status":124,"city":221,"state":222,"zip":223,"country":128,"countryCode":129,"cosmosGeoPoint":224,"geoPoint":228,"contacts":229},"University of Colorado","Aurora","Colorado","80045",{"type":131,"coordinates":225},[226,227],-104.83192,39.72943,{"lat":227,"lon":226},[230],{"name":231,"role":118,"phone":232,"phoneExt":83,"email":83},"Breelyn Wilky, MD","305-243-1287",{"facility":234,"status":124,"city":235,"state":236,"zip":237,"country":128,"countryCode":129,"cosmosGeoPoint":238,"geoPoint":242,"contacts":243},"Yale University School of Medicine","New Haven","Connecticut","06520",{"type":131,"coordinates":239},[240,241],-72.92816,41.30815,{"lat":241,"lon":240},[244],{"name":245,"role":118,"phone":246,"phoneExt":83,"email":83},"Michael Cecchini, MD","415-302-7807",{"facility":248,"status":124,"city":249,"state":250,"zip":251,"country":128,"countryCode":129,"cosmosGeoPoint":252,"geoPoint":256,"contacts":257},"Johns Hopkins University, Sibley Memorial Hospital","Washington D.C.","District of Columbia","20016",{"type":131,"coordinates":253},[254,255],-77.03637,38.89511,{"lat":255,"lon":254},[258],{"name":259,"role":118,"phone":260,"phoneExt":83,"email":83},"Mike J Pishvaian, MD\u002FPhD","202-804-3343",{"facility":123,"status":124,"city":262,"state":263,"zip":264,"country":128,"countryCode":129,"cosmosGeoPoint":265,"geoPoint":269,"contacts":270},"Jacksonville","Florida","32224",{"type":131,"coordinates":266},[267,268],-81.65565,30.33218,{"lat":268,"lon":267},[271],{"name":272,"role":118,"phone":273,"phoneExt":83,"email":83},"Conor O'Donnell, MD","904-953-6870",{"facility":275,"status":276,"city":277,"state":263,"zip":278,"country":128,"countryCode":129,"cosmosGeoPoint":279,"geoPoint":283,"contacts":83},"Florida Cancer Specialists","TERMINATED","Lake Mary","32746",{"type":131,"coordinates":280},[281,282],-81.31784,28.75888,{"lat":282,"lon":281},{"facility":285,"status":124,"city":286,"state":287,"zip":288,"country":128,"countryCode":129,"cosmosGeoPoint":289,"geoPoint":293,"contacts":294},"Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center","Baltimore","Maryland","21287",{"type":131,"coordinates":290},[291,292],-76.61219,39.29038,{"lat":292,"lon":291},[295,297],{"name":259,"role":118,"phone":296,"phoneExt":83,"email":83},"410-955-8964",{"name":298,"role":118,"phone":296,"phoneExt":83,"email":83},"Eric Christenson, MD",{"facility":300,"status":124,"city":301,"state":302,"zip":303,"country":128,"countryCode":129,"cosmosGeoPoint":304,"geoPoint":308,"contacts":309},"Massachusetts General Hospital","Boston","Massachusetts","02114",{"type":131,"coordinates":305},[306,307],-71.05977,42.35843,{"lat":307,"lon":306},[310],{"name":311,"role":118,"phone":312,"phoneExt":83,"email":83},"Samuel Klempner, MD","617-724-4000",{"facility":314,"status":124,"city":301,"state":302,"zip":315,"country":128,"countryCode":129,"cosmosGeoPoint":316,"geoPoint":318,"contacts":319},"Dana Farber Cancer Institute","02215",{"type":131,"coordinates":317},[306,307],{"lat":307,"lon":306},[320],{"name":321,"role":118,"phone":322,"phoneExt":83,"email":83},"Candace Haddox, MD","617-632-3000",{"facility":324,"status":124,"city":325,"state":326,"zip":327,"country":128,"countryCode":129,"cosmosGeoPoint":328,"geoPoint":332,"contacts":333},"M Health Fairview University of Minnesota Medical Center","Minneapolis","Minnesota","55455",{"type":131,"coordinates":329},[330,331],-93.26384,44.97997,{"lat":331,"lon":330},[334],{"name":335,"role":118,"phone":336,"phoneExt":83,"email":83},"Ajay Prakash, MD\u002FPhD","612-273-8383",{"facility":123,"status":124,"city":338,"state":326,"zip":339,"country":128,"countryCode":129,"cosmosGeoPoint":340,"geoPoint":344,"contacts":345},"Rochester","55905",{"type":131,"coordinates":341},[342,343],-92.4699,44.02163,{"lat":343,"lon":342},[346],{"name":347,"role":118,"phone":348,"phoneExt":83,"email":83},"Hao Xie, MD","504-284-2511",{"facility":350,"status":124,"city":351,"state":352,"zip":353,"country":128,"countryCode":129,"cosmosGeoPoint":354,"geoPoint":358,"contacts":359},"Washington University School of Medicine","St Louis","Missouri","63110",{"type":131,"coordinates":355},[356,357],-90.19789,38.62727,{"lat":357,"lon":356},[360],{"name":361,"role":118,"phone":362,"phoneExt":83,"email":83},"Moh'd Khushman, MD","314-362-9115",{"facility":364,"status":124,"city":365,"state":365,"zip":366,"country":128,"countryCode":129,"cosmosGeoPoint":367,"geoPoint":371,"contacts":372},"Memorial Sloan Kettering Cancer Center","New York","10065",{"type":131,"coordinates":368},[369,370],-74.00597,40.71427,{"lat":370,"lon":369},[373],{"name":374,"role":118,"phone":375,"phoneExt":83,"email":83},"Rona Yaeger, MD","646-888-5109",{"facility":377,"status":124,"city":378,"state":379,"zip":380,"country":128,"countryCode":129,"cosmosGeoPoint":381,"geoPoint":385,"contacts":386},"Duke University","Durham","North Carolina","27705",{"type":131,"coordinates":382},[383,384],-78.89862,35.99403,{"lat":384,"lon":383},[387],{"name":388,"role":118,"phone":389,"phoneExt":83,"email":83},"Niharika Mettu, MD","919-681-2954",{"facility":391,"status":124,"city":392,"state":393,"zip":394,"country":128,"countryCode":129,"cosmosGeoPoint":395,"geoPoint":399,"contacts":400},"University Hospitals Cleveland Medical Center, Seidman Cancer Center","Cleveland","Ohio","44106",{"type":131,"coordinates":396},[397,398],-81.69541,41.4995,{"lat":398,"lon":397},[401],{"name":402,"role":118,"phone":403,"phoneExt":83,"email":83},"David Bajor, MD","216-765-9033",{"facility":405,"status":124,"city":392,"state":393,"zip":406,"country":128,"countryCode":129,"cosmosGeoPoint":407,"geoPoint":409,"contacts":410},"Cleveland Clinic","44195",{"type":131,"coordinates":408},[397,398],{"lat":398,"lon":397},[411,414],{"name":412,"role":118,"phone":413,"phoneExt":83,"email":83},"Wen Wee Ma, MBBS","216-444-2200",{"name":415,"role":118,"phone":416,"phoneExt":83,"email":83},"Dale Shepard, MD, PhD","(216) 444-2200",{"facility":418,"status":124,"city":419,"state":420,"zip":421,"country":128,"countryCode":129,"cosmosGeoPoint":422,"geoPoint":426,"contacts":427},"Oregon Health and Science University","Portland","Oregon","97239",{"type":131,"coordinates":423},[424,425],-122.67621,45.52345,{"lat":425,"lon":424},[428],{"name":429,"role":118,"phone":430,"phoneExt":83,"email":83},"Shivaani Kummar, MD","503-494-8534",{"facility":432,"status":124,"city":433,"state":434,"zip":435,"country":128,"countryCode":129,"cosmosGeoPoint":436,"geoPoint":440,"contacts":441},"University of Pennsylvania, Perelman School of Medicine","Philadelphia","Pennsylvania","19104",{"type":131,"coordinates":437},[438,439],-75.16362,39.95238,{"lat":439,"lon":438},[442],{"name":443,"role":118,"phone":444,"phoneExt":83,"email":83},"Mark O'Hara, MD","215-662-4646",{"facility":446,"status":124,"city":447,"state":434,"zip":448,"country":128,"countryCode":129,"cosmosGeoPoint":449,"geoPoint":453,"contacts":454},"University of Pittsburgh Medical Center, Hillman Cancer Center","Pittsburgh","15232",{"type":131,"coordinates":450},[451,452],-79.99589,40.44062,{"lat":452,"lon":451},[455],{"name":456,"role":118,"phone":457,"phoneExt":83,"email":83},"Dennis J Hsu, MD","412-623-1722",{"facility":459,"status":124,"city":460,"state":461,"zip":462,"country":128,"countryCode":129,"cosmosGeoPoint":463,"geoPoint":467,"contacts":468},"Sarah Cannon Research Institute","Nashville","Tennessee","37203",{"type":131,"coordinates":464},[465,466],-86.78444,36.16589,{"lat":466,"lon":465},[469],{"name":470,"role":118,"phone":471,"phoneExt":83,"email":83},"Meredith S Pelster, MD","615-329-6862",{"facility":473,"status":124,"city":460,"state":461,"zip":474,"country":128,"countryCode":129,"cosmosGeoPoint":475,"geoPoint":477,"contacts":478},"Vanderbilt Ingram Cancer Center","37232",{"type":131,"coordinates":476},[465,466],{"lat":466,"lon":465},[479],{"name":480,"role":118,"phone":481,"phoneExt":83,"email":83},"Kristen Ciombor, MD","615-322-3000",{"facility":483,"status":124,"city":484,"state":485,"zip":486,"country":128,"countryCode":129,"cosmosGeoPoint":487,"geoPoint":491,"contacts":492},"The University of Texas MD Anderson Cancer Center","Houston","Texas","77030",{"type":131,"coordinates":488},[489,490],-95.36327,29.76328,{"lat":490,"lon":489},[493],{"name":494,"role":118,"phone":495,"phoneExt":83,"email":83},"Jordi Rodon Ahnert, MD\u002FPhD","713-792-5603",{"facility":497,"status":124,"city":498,"state":485,"zip":499,"country":128,"countryCode":129,"cosmosGeoPoint":500,"geoPoint":504,"contacts":505},"South Texas Accelerated Research Therapeutics, LLC","San Antonio","78229",{"type":131,"coordinates":501},[502,503],-98.49363,29.42412,{"lat":503,"lon":502},[506],{"name":507,"role":118,"phone":508,"phoneExt":83,"email":83},"Kyriakos Papadopoulos, MD","210-593-5255",{"facility":510,"status":124,"city":511,"state":512,"zip":513,"country":128,"countryCode":129,"cosmosGeoPoint":514,"geoPoint":518,"contacts":519},"University of Virginia","Charlottesville","Virginia","22908",{"type":131,"coordinates":515},[516,517],-78.47668,38.02931,{"lat":517,"lon":516},[520],{"name":521,"role":118,"phone":522,"phoneExt":83,"email":83},"Ludimila Cavalcante, MD","434-358-8780",{"facility":524,"status":124,"city":525,"state":526,"zip":527,"country":128,"countryCode":129,"cosmosGeoPoint":528,"geoPoint":532,"contacts":533},"University of Wisconsin, Carbone Cancer Center","Madison","Wisconsin","53705",{"type":131,"coordinates":529},[530,531],-89.40123,43.07305,{"lat":531,"lon":530},[534],{"name":535,"role":118,"phone":536,"phoneExt":83,"email":83},"Jeremy Kratz, MD","608-263-1300",{"facility":538,"status":124,"city":539,"state":540,"zip":541,"country":542,"countryCode":543,"cosmosGeoPoint":544,"geoPoint":548,"contacts":549},"Integrated Clinical Oncology Network (ICON)","South Brisbane","Queensland","4101","Australia","AU",{"type":131,"coordinates":545},[546,547],153.02049,-27.48034,{"lat":547,"lon":546},[550],{"name":551,"role":118,"phone":552,"phoneExt":83,"email":83},"Vladimir Andelkovic, MD","+61755198211",{"facility":554,"status":124,"city":555,"state":556,"zip":557,"country":542,"countryCode":543,"cosmosGeoPoint":558,"geoPoint":562,"contacts":563},"Peter MacCallum Cancer Centre","Melbourne","Victoria","3000",{"type":131,"coordinates":559},[560,561],144.96332,-37.814,{"lat":561,"lon":560},[564],{"name":565,"role":118,"phone":566,"phoneExt":83,"email":83},"Jeremy Lewin, MD","+61385595000",{"type":568,"investigatorFullName":83,"investigatorTitle":83,"investigatorAffiliation":83,"oldNameTitle":83,"oldOrganization":83},"SPONSOR","100509886","phase-1-fog-001-in-locally-advanced-or-metastatic-solid-tumors-100509886",false,"NCT05919264","FOG-001 in Locally Advanced or Metastatic Solid Tumors","A Phase 1\u002F2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors","Inclusion Criteria:\n\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.\n* Adequate organ and marrow function.\n\nAdditional Inclusion Criteria for Dose Escalation Cohorts (Part 1a and Part 1g):\n\n* Diagnosis of treatment-refractory advanced\u002Fmetastatic solid tumor that is non-MSI-H or non-dMMR colorectal cancer (CRC) or any other solid tumor with documented WNT- pathway activating mutations (WPAMs).\n\nAdditional Inclusion Criteria for Dose Escalation Cohorts (Part 1b):\n\n* Diagnosis of treatment-refractory advanced\u002Fmetastatic non-MSI-H or non-dMMR CRC.\n* At least one lesion that is suitable for a core needle biopsy.\n\nAdditional Inclusion Criteria for Dose Escalation and Dose Expansion Cohorts (Part 1c and Part 2c):\n\n* Histologically, cytologically, or radiographically confirmed HCC with a documented WPAM (by local ctDNA or tumor NGS testing) in APC or CTNNB1\n\nAdditional Inclusion Criteria for Dose Escalation and Dose Expansion Cohorts (Part 1d, Part 1h, and Part 2d):\n\n* Desmoid tumor (aggressive fibromatosis)\n\nAdditional Inclusion Criteria for Dose Escalation and Dose Expansion Cohorts (Part 1f-1 and Part 2f-1) FOG-001 + FOLFOX + Bevacizumab:\n\n* Diagnosis of locally advanced or metastatic non-MSI-H or non-dMMR CRC\n* Participants with tumors known to be negative for APC LoF mutations or CTNNB1 GoF mutations (per NGS tests) are not eligible.\n* One dose of mFOLFOX6 with or without bevacizumab in the unresectable or metastatic setting prior to enrollment is allowed.\n\nAdditional Inclusion Criteria for Dose Escalation and Dose Expansion Cohorts (Part 1f-2 and Part 2f-2): FOG-001 + Nivolumab\n\n* Non-MSI-H or non-dMMR (by local testing) CRC with or without liver metastases.\n* MSI-H CRC or solid tumors that are WPAM and resistant to a-PD-1\u002FPD-L1\n* Participants with tumors known to be negative for APC LoF mutations or CTNNB1 GoF mutations (per NGS tests) are not eligible\n\nAdditional Inclusion Criteria for Dose Escalation and Dose Expansion Cohorts (Part 1f-3 and Part 2f-3): FOG-001 + Trifluridine\u002FTipiracil + Bevacizumab\n\n* Diagnosis of locally advanced or metastatic non-MSI-H or non-dMMR (by local testing) CRC\n* Participants with tumors known to be negative for APC LoF mutations or CTNNB1 GoF mutations (per NGS tests) are not eligible.\n\nAdditional Inclusion Criteria for Dose Expansion Cohort (Part 2a):\n\n* Diagnosis of locally advanced or metastatic non-MSI-H or non-dMMR (by local testing) CRC\n\nAdditional Inclusion Criteria for Dose Expansion Cohort (Part 2b):\n\n* Diagnosis of advanced or metastatic solid tumors with a documented WPAM (by local testing) or equivalent evidence\n\nExclusion Criteria:\n\n* Known history of bone metastasis. Bone metastasis are allowed for patients with mCRPC.\n* Evidence of vertebral compression fracture or non-traumatic bone fracture within the past 12 months and who are not receiving antiresorptive therapy.\n* Osteoporosis, which is defined as a T-score of ≤-2.5 at the lumbar spine (L1 - L4), left (or right) femoral neck or left (or right) total hip as determined by DXA scan.\n* Uncontrolled inflammatory bowel disease (i.e., ulcerative colitis or Crohn's disease)\n* Unstable\u002Finadequate cardiac function.\n* Has known meningeal carcinomatosis, leptomeningeal carcinomatosis, spinal cord compression, or symptomatic or unstable brain metastases.\n* Pregnant, lactating, or planning to become pregnant.","ALL","18 Years",{"count":579,"type":580},595,"ESTIMATED","INTERVENTIONAL",[583,584],"PHASE1","PHASE2","The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.",[587,588,589,590,591,592,593,594,595,596,597,598,599,600,601],"Cancer","Colorectal Cancer","Solid Tumor","Locally Advanced Solid Tumor","Metastatic Cancer","WNT Pathway","HCC","Desmoid","Microsatellite Stable Colorectal Cancer","Metastatic Castration-resistant Prostate Cancer","FAP","Endometrial Carcinoma","Prostate Cancer","Microsatellite Instability-High Colorectal Cancer","Adamantinomatous Craniopharyngioma",[587,589,590,591,603,604,605,594,606,607,608,609,610],"WNT Pathway Activating Mutation (WPAM)","Colorectal Cancer (CRC)","Microsatellite Stable (MSS)","Hepatocellular Carcinoma (HCC)","Adenomatous Polyposis Coli (APC)","β-catenin","Beta-catenin","CTNNB1","2026-05-26",{"date":613,"type":614},"2026-05-28","ACTUAL",{"date":616,"type":614},"2023-05-23",{"date":618,"type":580},"2027-08-31",{"name":5,"class":6},33]